Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VERU INC. Director's Dealing 2017

May 15, 2017

34598_dirs_2017-05-15_7bee0f86-da18-4e15-9955-a3765c47b014.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FEMALE HEALTH CO (FHCO)
CIK: 0000863894
Period of Report: 2017-05-11

Reporting Person: BETHUNE DAVID R (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-05-11 Common Stock, par value $0.01 per share P 10000 $1.0278 Acquired 415982 Direct
2017-05-12 Common Stock, par value $0.01 per share P 10000 $1.0299 Acquired 425982 Direct

Footnotes

F1: The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.019 to $1.03. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price.

F2: The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.00 to $1.03. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price.